𝔖 Bobbio Scriptorium
✦   LIBER   ✦

UV light killing efficacy of fluorescent protein-expressing cancer cells in vitro and in vivo

✍ Scribed by Hiroaki Kimura; Claudia Lee; Katsuhiro Hayashi; Kensuke Yamauchi; Norio Yamamoto; Hiroyuki Tsuchiya; Katsuro Tomita; Michael Bouvet; Robert M. Hoffman


Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
978 KB
Volume
110
Category
Article
ISSN
0730-2312

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

We investigated the cell‐killing efficacy of UV light on cancer cells expressing GFP in the nucleus and RFP in the cytoplasm (dual‐color cells). After exposure to various doses of UVA, UVB, or UVC, apoptotic and viable cells were quantitated under fluorescence microscopy using dual‐color 143B human osteosarcoma cells, HT‐1080 human fibrosarcoma cells, Lewis lung carcinoma (LLC), and XPA‐1 human pancreatic cancer cells in vitro. UV‐induced cancer cell death was wave‐length and dose dependent, as well as cell‐line dependent. After UVA exposure, most cells were viable even when the UV dose was increased up to 200 J/m^2^. With UVB irradiation, cell death was observed with irradiation at 50 J/m^2^. For UVC, as little as 25 J/m^2^ UVC irradiation killed approximately 70% of the 143B dual‐color cells. This dose of UVB or UVA had almost no effect on the cancer cells. UV‐induced cancer cell death varied among the cell lines. Cell death began about 4 h after irradiation and continued until 10 h after irradiation. UVC exposure also suppressed cancer cell growth in nude mice in a model of minimal residual cancer (MRC). No apparent side effects of UVC exposure were observed. This study opens up the possibility of UVC treatment for MRC after surgical resection. J. Cell. Biochem. 110: 1439–1446, 2010. © 2010 Wiley‐Liss, Inc.


📜 SIMILAR VOLUMES


Downregulation of XIAP expression in ova
✍ Tanya J. Shaw; Eric C. Lacasse; Jon P. Durkin; Barbara C. Vanderhyden 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 French ⚖ 170 KB

## Abstract A hallmark of cancer cells is an ability to evade apoptosis. Overexpression and/or activating mutations of prosurvival molecules such as the X‐linked inhibitor of apoptosis (XIAP) contribute to this inappropriate cell survival. Our objectives were to investigate the effects of downregul

Quantification of tumor cell injury in v
✍ Xinjian Lin; Dennis P. Gately; Doreen Hom; Misako Mishima; Gerrit Los; Stephen B 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 French ⚖ 145 KB 👁 2 views

The GADD153 gene is strongly transcriptionally activated by many types of cellular injury and the magnitude of the change in GADD153 expression is proportional to the extent of damage. We developed a novel reporter system in which a chimeric gene containing the GADD153 promoter linked to the coding

Serial in vivo loss and in vitro gain of
✍ Soroosh Radfar; Christian Davrinche; Etienne Hollande 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 French ⚖ 512 KB

## Abstract Recent studies have shown the involvement of the Fas system (Fas receptor and its ligand FasL) in cancerous processes. The absence or downregulation of Fas, reported in the majority of human tumors, conflicts with its presence in cancerous cells from the same tumors but maintained __in

Bispecific antibody targeting of doxorub
✍ C.H.J. Ford; P.A. Osborne; B.G. Rego; A. Mathew 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 French ⚖ 120 KB

A bispecific monoclonal antibody (BsMAb) recognising carcinoembryonic antigen (CEA) and doxorubicin (Dox) was used in colorimetric microcytotoxicity assays with 3 human colon cancer cell lines (COLO320DM, SKCO1 and LS174T) showing no, high or medium CEA expression, respectively. The IC50 values for